Skip to main content
Back to SMBC Venture Capital

SMBC Venture Capital's Therapeutics Portfolio

Browse 9 Therapeutics companies funded by SMBC Venture Capital. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
9
Total Funding in Therapeutics
$127.5M

Therapeutics Portfolio Companies (9)

Export
BiotechnologyLife ScienceTherapeutics

ThinkCyte is a biotechnology company that provides sorting of cells for various applications in research, diagnostics, and therapeutics.

Hongo, Japan
August 2024
$14.8M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

Tokyo, Japan
June 2026
$32.8M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingTherapeutics

Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.

Minamimachi, Japan
April 2024
$7.6M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

Tokyo, Japan
April 2026
$8.2M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Health CareManufacturingMedicalTherapeutics

Airato is a radiotherapy provider that uses artificial intelligence to develop radiation therapy and other medical devices.

Miyagi, Japan
October 2025
$1.1M
Seed

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

RadioNano Therapeutics is a medical technology company that develops radiation therapy solutions for the treatment of cancer patients.

Kyoto, Japan
December 2024
$955K
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsMedicalTherapeutics

Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.

Tsuruoka, Japan
February 2026
$7.6M
Series B

Founder Contacts

30,000+ verified contacts

Addiction TreatmentHealth CareMedicalMobile AppsSoftwareTherapeutics

CureApp is a digital health and therapeutic medical device software that connects patients and doctors.

Tokyo, Japan
August 2022
$52.1M
Series G

Founder Contacts

30,000+ verified contacts

Health CareMedicalTherapeutics

Thyas provides preparations of regenerative immunocell therapy for cancer and infection.

Kyoto, Japan
November 2019
$2.2M
Series Unknown

Founder Contacts

30,000+ verified contacts

Explore SMBC Venture Capital's Full Portfolio

View all companies funded by SMBC Venture Capital across every industry and funding stage.

View Full SMBC Venture Capital Portfolio